Regencell Bioscience Holdings (NASDAQ: RGC) Stock News Today: Price Action, DOJ Probe Overhang, and the Latest Forecasts on Dec. 24, 2025
Regencell Bioscience (RGC) closed at $24.60 on Dec. 24, down 2.57%, with about 348,000 shares traded and a market cap near $12.16 billion. The stock remains volatile amid concentrated insider ownership, a DOJ inquiry into trading, and no reported revenue. The company focuses on Traditional Chinese Medicine for neurocognitive disorders, with operations in Hong Kong.